ASTRAZENECA is in talks with Summit Therapeutics to license an experimental lung-cancer drug under a deal worth as much as $15 billion, Bloomberg News reported on Thursday, citing people familiar with ...

A fundraising web page set up by a Southam woman after her husband suffered a brain aneurysm and was later diagnosed with ...

Just hours after delighting staff and patients with a visit to Colchester Hospital to discuss her cancer journey, the ...

Dr Bradshaw has shared six signs of breast cancer you should never ignore, they include: Dr Bradshaw said: “If you are ...